Effects of pituitary adenylate cyclase-activating polypeptide on canine atrial electrophysiology.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 11557557)

Published in Am J Physiol Heart Circ Physiol on October 01, 2001

Authors

M Hirose1, Z Leatmanoratn, K R Laurita, M D Carlson

Author Affiliations

1: Department of Pharmacology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Articles by these authors

Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation (1999) 4.51

Unique properties of cardiac action potentials recorded with voltage-sensitive dyes. J Cardiovasc Electrophysiol (1996) 2.42

Impact of a guideline-based disease management team on outcomes of hospitalized patients with congestive heart failure. Arch Intern Med (2001) 2.28

Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res (1995) 2.15

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol (2001) 1.68

Classification of death in antiarrhythmia trials. J Am Coll Cardiol (1996) 1.44

Optical mapping in a new guinea pig model of ventricular tachycardia reveals mechanisms for multiple wavelengths in a single reentrant circuit. Circulation (1996) 1.18

Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia. Circulation (2000) 1.18

Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up. J Am Coll Cardiol (2001) 1.16

Cellular basis for dispersion of repolarization underlying reentrant arrhythmias. J Electrocardiol (2000) 1.00

Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. Circulation (1999) 0.94

Characterization of sinoatrial parasympathetic innervation in humans. J Cardiovasc Electrophysiol (1999) 0.94

Salvage of infected ICDs: management without removal. Pacing Clin Electrophysiol (1996) 0.94

Attitudes of faculty, housestaff, and medical students toward clinical practice guidelines. Acad Med (1999) 0.93

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol (1999) 0.93

Tachycardia-induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: improvement of left ventricular systolic function after radiofrequency catheter ablation of the arrhythmia. J Cardiovasc Electrophysiol (1997) 0.92

Occult T wave alternans in long QT syndrome. J Cardiovasc Electrophysiol (1996) 0.91

Right ventricular arrhythmia in the absence of arrhythmogenic dysplasia: MR imaging of myocardial abnormalities. Radiology (1998) 0.90

Independent ablation of retrograde and anterograde accessory connection conduction at the atrial and ventricular insertion sites: evidence supporting the impedance mismatch hypothesis for unidirectional block. J Cardiovasc Electrophysiol (1994) 0.88

Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block. Eur Heart J (1995) 0.86

Cardiovascular emergencies. Semin Oncol (1989) 0.84

Cardiac electrical responses to vagal stimulation of fibers to discrete cardiac regions. Am J Physiol (1990) 0.83

Evolving patterns in the surgical treatment of malignant ventricular tachyarrhythmias. Ann Thorac Surg (1990) 0.83

Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. Pacing Clin Electrophysiol (1997) 0.82

Transcatheter radiofrequency ablation of ventricular tachycardia following surgical correction of tetralogy of Fallot. Pacing Clin Electrophysiol (1994) 0.82

Atrial fibrillation: a risk factor for increased mortality--an AVID registry analysis. J Interv Card Electrophysiol (2001) 0.82

Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation (1994) 0.81

Ventricular arrhythmias in perspective: a current view. Am Heart J (1992) 0.81

Endocardial stimulation of efferent parasympathetic nerves to the atrioventricular node in humans: optimal stimulation sites and the effects of digoxin. J Interv Card Electrophysiol (2001) 0.81

Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion. Circulation (1992) 0.81

Strategies in the surgical treatment of malignant ventricular arrhythmias. An 8-year experience. Ann Surg (1992) 0.80

Current-based transthoracic defibrillation. Am J Cardiol (1996) 0.79

Favorable results of implantable cardioverter-defibrillator implantation in patients older than 70 years. Ann Thorac Surg (1997) 0.78

Design and implementation of an inpatient disease management program. Am J Manag Care (2000) 0.78

CNP causes receptor-mediated positive dromotropic effects in anesthetized dog hearts. Am J Physiol (1998) 0.77

An increase in sinus rate following radiofrequency energy application in the posteroseptal space. Pacing Clin Electrophysiol (1998) 0.77

New evidence that AV node slow pathway conduction directly influences fast pathway function. J Cardiovasc Electrophysiol (1998) 0.77

Classification of death in clinical trials: precision versus accuracy. J Cardiovasc Electrophysiol (1999) 0.76

Selective surgical approach for atrioventricular reentrant tachycardia. Ann Thorac Surg (1992) 0.76

Prolongation of cardiac cycle length attenuates negative dromotropic response to selective vagal stimuli. J Auton Nerv Syst (1989) 0.76

New directions in intraoperative mapping and surgical treatment of ventricular tachycardia. Circulation (1991) 0.75

Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study. J Am Coll Cardiol (1993) 0.75

Efficacy and safety of moricizine in the maintenance of sinus rhythm in patients with recurrent atrial fibrillation. Am J Cardiol (2001) 0.75

Fatigue fracture analysis of amalgam by SEM-EDS. Dent Mater (1986) 0.75

Regular wide QRS complex tachycardia during atrial fibrillation in a patient with preexcitation syndrome: a case report. J Cardiovasc Electrophysiol (1995) 0.75

Mechanism for pituitary adenylate cyclase-activating polypeptide-induced atrial fibrillation. J Cardiovasc Electrophysiol (2001) 0.75

Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Auton Nerv Syst (1993) 0.75

Nerve outgrowth by dorsal root ganglia in vitro: stimulation by inhibitors of DNA metabolism in the absence of exogenous nerve growth factor. Differentiation (1979) 0.75

Systolic blood pressure at rest, not the degree of beta blockade, predicts the result of follow-up tilt-table testing for vasovagal syncope. Am J Cardiol (1997) 0.75

Late results with concomitant coronary artery bypass grafting and ICD implantation. J Card Surg (1997) 0.75

Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy. J Am Coll Cardiol (1995) 0.75

Atrial flutter causes pseudo late potentials on signal-averaged electrocardiogram. Am J Cardiol (1993) 0.75

Combined internal cardioverter-defibrillator implantation and myocardial revascularization for ischemic ventricular arrhythmias: optimal cost-effective strategy. Cardiovasc Surg (1995) 0.75

Post open heart surgery ventricular arrhythmias. Cardiovasc Clin (1992) 0.75

Angiotensin-converting enzyme inhibition produces electrophysiologic but not antiarrhythmic effects in the intact heart. J Cardiovasc Pharmacol (1998) 0.75

Persistent T-wave changes after radiofrequency catheter ablation of an accessory connection (Wolff-parkinson-white syndrome) are caused by "cardiac memory". Am Heart J (1999) 0.75

General evaluation of out-of-hospital sudden cardiac death survivors. Circulation (1992) 0.75

A perspective on ventricular arrhythmias: patient assessment for therapy and outcome. Am J Cardiol (1990) 0.75